SCHEDULE OF THE DAY

8:30 to 8:45 am
Welcome and Review of the Clinical Day by
Dr. Ernesto Schiffrin
Overview of General Learning Objectives by
Drs. Susie Lau and Shannon Salvador

MORNING SESSION

8:45 - 9:15 am
Dr. Pedro T. Ramirez - Impact of Surgical Trials on Clinical Practice: Trial Guidelines and Implementation of Innovation

9:15 - 9:25 am | Q&A Interactivity Presentation 1

9:25 - 10:05 am
Drs. Susie Lau and Shannon Salvador - Revolutionizing Women's Cancer Care: Exploring Innovations in Precision Surgery

10:05 - 10:15 am | Q&A Interactivity Presentation 2

10:15 - 10:45 am | Health Break

10:45 - 11:15 am
Dr. Mario M. Leitao, Jr. - The Role and Evaluation of Robotic Surgical Platforms

11:15 - 11:25 am | Q&A Interactivity Presentation 3

11:25 - 11:55 am
Dr. Jessica McAlpine - Precision Oncology in Endometrial Cancer

11:55 am - 12:05 pm | Q&A Interactivity Presentation 4

12:05 - 12:15 pm | Morning Session Q&A Interactivity

12:15 - 1:15 pm | Lunch Break

AFTERNOON SESSION

1:15 - 1:45 pm
Dr. David Huntsman - Cell Context, Mutation, Microenvironment and Ovarian Cancer Control

1:25 - 1:35 pm | Q&A Interactivity Presentation 5

1:55 - 2:25 pm
Dr. Robert Coleman - The implementation of novel therapeutics and strategies in advanced/recurrent Cervix Cancer

2:25 - 2:35 pm | Q&A Interactivity Presentation 6

2:35 - 2:45 pm | Afternoon Session Q&A Interactivity

2:45 - 3:45 pm | Conclusion, adjournment and symposium discussion

SCIENTIFIC CHAIR
Ernesto L. Schiffrin, C.M., MD, PhD, FRSC, FRCPC, FACP
Distinguished James McGill Professor, Department of Medicine, McGill University,
Director, Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research,
Director, Cardiovascular Prevention Centre and
Physician-in-Chief Emeritus, Sir Mortimer B. Davis-Jewish General Hospital

CO-CHAIRS AND GUEST LECTURERS
Susie K.S. Lau, MD, MSc, FRCS
Associate Professor, Obstetric, Gynecology and Oncology, McGill University
Vice-President, Regroupement des Gynécologues Oncologues du Québec (RGOQ)
Leader, Gynecologic Oncology Clinical Trials, Jewish General Hospital

Shannon Salvador, MD, MSc, FRCSC
President Elect, The Society of Gynecologic Oncology of Canada (GOC)
Associate Professor, Gynecologic Oncology, McGill University
Program Director, Gynecologic Oncology Residency Program
Head of Colposcopy, Jewish General Hospital

GUEST LECTURERS
Robert L. Coleman, MD, FACOG, FACS
Chief Medical Officer, Vanaim Group
Gynecologic Oncologist, Texas Oncology (US Oncology Network) The Woodlands, TX

David Huntsman, MD, FRCPC, FCCMG, FRSC, FCAHS
Chew Wei Professor of Gynaecologic Oncology
Professor, Departments of Pathology and Lab Medicine and Obstetrics and Gynaecology, UBC
Director of OVCARE, Vancouver General Hospital, BC Cancer Agency and UBC
Distinguished Scientist, Department of Molecular Oncology, BC Cancer Agency Research Centre
Canada Research Chair in Molecular and Genomic Pathology

Mario M. Leitao, Jr., MD
Attending Surgeon & Member, Division of Gynecology
Professor, Weill Cornell Medical College
Director, Gynecologic Oncology Fellowship Program
Director, Minimal Access and Robotic Surgery (MARS) Program
Department of Surgery
Memorial Sloan-Kettering Cancer Center

Jessica McAlpine, MD
Tier 1 Canada Research Chair in Molecular Stratification in Gynecologic Cancers
Chew Wei Chair in Gynecologic Oncology
Co-Division Head, Gynecologic Oncology
Professor, Department of Obstetrics and Gynecology
Gynecologic Tissue Bank Director, www.ovcare.ca
University of British Columbia, Vancouver Coastal Health Research Institute and BC Cancer

Pedro T. Ramirez, MD
Chair, Department of Obstetrics and Gynecology
Houston Methodist Hospital
Neal Cancer Center
Editor-in-Chief, International Journal of Gynecological Cancer

MODERATORS
Gerald Batist, MD, FRCP(C), FACP, FCAHS, C.M., C.Q.
Director, Segal Cancer Centre (Chief, Dept. of Oncology), Jewish General Hospital
Director, McGill Centre for Translational Research in Cancer, Professor, Department of Oncology, McGill University

Melica Brodeur, MD
Assistant Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, McGill University

Beatrice Cormier, MD
Clinical Assistant Professor
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Montreal

Marie Plante, MD
Professor, Department of Obstetrics and Gynecology, Laval University
Gynecologic Oncologist, CHU de Québec, l’Hôtel-Dieu de Québec

THE OVERALL LEARNING OBJECTIVES
- Apply the innovations in molecular, translational, and surgical approaches in the treatment of gynecologic cancers.
- Identify the new advances in precision medicine and precision surgery, and their evaluation.
- Identify the increased value of robotic surgery considering both the clinical outcome of patients and the cost savings for the institution.

This program meets the accreditation criteria as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada and has been accredited by the Office for Continuing Professional Development, Faculty of Medicine and Health Sciences, McGill University for up to 5.75 Section 1 (Accredited Group Learning Activity) credits/hours.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme

This one-credit-per-hour Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by the Office for Continuing Professional Development, Faculty of Medicine and Health Sciences for up to 5.75 Mainpro+ credits.

Members of the American Academy of Family Physicians are eligible to receive up to 5.75 Prescribed credit hours for attendance at this meeting/event due to a reciprocal agreement with the College of Family Physicians of Canada.

CERT+ Session ID: 198359-001